Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Suppression of experimental abdominal aortic aneurysms in the mice by treatment with Ginkgo biloba extract (EGb 761).

Wang L, Bai Y, Wang B, Cui H, Wu H, Lv JR, Mei Y, Zhang JS, Liu S, Qi LW, Chen Y.

J Ethnopharmacol. 2013 Oct 28;150(1):308-15. doi: 10.1016/j.jep.2013.08.048. Epub 2013 Sep 5.

PMID:
24012526
2.

Suppression of abdominal aortic aneurysm formation by inhibition of prolyl hydroxylase domain protein through attenuation of inflammation and extracellular matrix disruption.

Watanabe A, Ichiki T, Sankoda C, Takahara Y, Ikeda J, Inoue E, Tokunou T, Kitamoto S, Sunagawa K.

Clin Sci (Lond). 2014 May;126(9):671-8. doi: 10.1042/CS20130435.

PMID:
24256203
4.

Resveratrol prevents the development of abdominal aortic aneurysm through attenuation of inflammation, oxidative stress, and neovascularization.

Kaneko H, Anzai T, Morisawa M, Kohno T, Nagai T, Anzai A, Takahashi T, Shimoda M, Sasaki A, Maekawa Y, Yoshimura K, Aoki H, Tsubota K, Yoshikawa T, Okada Y, Ogawa S, Fukuda K.

Atherosclerosis. 2011 Aug;217(2):350-7. doi: 10.1016/j.atherosclerosis.2011.03.042. Epub 2011 Apr 8.

PMID:
21530968
5.

Role of vascular endothelial growth factor-A in development of abdominal aortic aneurysm.

Kaneko H, Anzai T, Takahashi T, Kohno T, Shimoda M, Sasaki A, Shimizu H, Nagai T, Maekawa Y, Yoshimura K, Aoki H, Yoshikawa T, Okada Y, Yozu R, Ogawa S, Fukuda K.

Cardiovasc Res. 2011 Jul 15;91(2):358-67. doi: 10.1093/cvr/cvr080. Epub 2011 Mar 24.

PMID:
21436157
6.

Quercetin, a flavonoid with anti-inflammatory activity, suppresses the development of abdominal aortic aneurysms in mice.

Wang L, Wang B, Li H, Lu H, Qiu F, Xiong L, Xu Y, Wang G, Liu X, Wu H, Jing H.

Eur J Pharmacol. 2012 Sep 5;690(1-3):133-41. doi: 10.1016/j.ejphar.2012.06.018. Epub 2012 Jun 19.

PMID:
22728078
7.

Differential regulation of the superoxide dismutase family in experimental aortic aneurysms and rat aortic explants.

Sinha I, Pearce CG, Cho BS, Hannawa KK, Roelofs KJ, Stanley JC, Henke PK, Upchurch GR Jr.

J Surg Res. 2007 Apr;138(2):156-62. Epub 2006 Dec 29.

PMID:
17196988
8.

Suppression of abdominal aortic aneurysm formation by AR-R17779, an agonist for the α7 nicotinic acetylcholine receptor.

Watanabe A, Ichiki T, Kojima H, Takahara Y, Hurt-Camejo E, Michaëlsson E, Sankoda C, Ikeda J, Inoue E, Tokunou T, Kitamoto S, Sunagawa K.

Atherosclerosis. 2016 Jan;244:113-20. doi: 10.1016/j.atherosclerosis.2015.11.006. Epub 2015 Nov 17.

PMID:
26613536
9.

Cigarette smoking increases aortic dilatation without affecting matrix metalloproteinase-9 and -12 expression in a modified mouse model of aneurysm formation.

Bergoeing MP, Arif B, Hackmann AE, Ennis TL, Thompson RW, Curci JA.

J Vasc Surg. 2007 Jun;45(6):1217-1227. Epub 2007 Mar 29.

10.

Lipocalin-2 deficiency or blockade protects against aortic abdominal aneurysm development in mice.

Tarín C, Fernandez-Garcia CE, Burillo E, Pastor-Vargas C, Llamas-Granda P, Castejón B, Ramos-Mozo P, Torres-Fonseca MM, Berger T, Mak TW, Egido J, Blanco-Colio LM, Martín-Ventura JL.

Cardiovasc Res. 2016 Aug 1;111(3):262-73. doi: 10.1093/cvr/cvw112. Epub 2016 May 26.

PMID:
27229458
11.

Chemokine (C-X-C motif) receptor 4 blockade by AMD3100 inhibits experimental abdominal aortic aneurysm expansion through anti-inflammatory effects.

Michineau S, Franck G, Wagner-Ballon O, Dai J, Allaire E, Gervais M.

Arterioscler Thromb Vasc Biol. 2014 Aug;34(8):1747-55. doi: 10.1161/ATVBAHA.114.303913. Epub 2014 May 29.

12.

Exploration of the mechanisms by which 3,4-benzopyrene promotes angiotensin II-induced abdominal aortic aneurysm formation in mice.

Ji K, Zhang Y, Jiang F, Qian L, Guo H, Hu J, Liao L, Tang J.

J Vasc Surg. 2014 Feb;59(2):492-9. doi: 10.1016/j.jvs.2013.03.022. Epub 2013 May 12.

13.

Zinc Prevents Abdominal Aortic Aneurysm Formation by Induction of A20-Mediated Suppression of NF-κB Pathway.

Yan YW, Fan J, Bai SL, Hou WJ, Li X, Tong H.

PLoS One. 2016 Feb 26;11(2):e0148536. doi: 10.1371/journal.pone.0148536. eCollection 2016.

15.

Pharmacological inhibitor of notch signaling stabilizes the progression of small abdominal aortic aneurysm in a mouse model.

Cheng J, Koenig SN, Kuivaniemi HS, Garg V, Hans CP.

J Am Heart Assoc. 2014 Oct 27;3(6):e001064. doi: 10.1161/JAHA.114.001064.

16.

Treatment with simvastatin suppresses the development of experimental abdominal aortic aneurysms in normal and hypercholesterolemic mice.

Steinmetz EF, Buckley C, Shames ML, Ennis TL, Vanvickle-Chavez SJ, Mao D, Goeddel LA, Hawkins CJ, Thompson RW.

Ann Surg. 2005 Jan;241(1):92-101.

17.

Castration of male mice prevents the progression of established angiotensin II-induced abdominal aortic aneurysms.

Zhang X, Thatcher S, Wu C, Daugherty A, Cassis LA.

J Vasc Surg. 2015 Mar;61(3):767-76. doi: 10.1016/j.jvs.2013.11.004. Epub 2014 Jan 16.

18.

The antioxidant activity of standardized extract of Ginkgo biloba (EGb 761) in rats.

Bridi R, Crossetti FP, Steffen VM, Henriques AT.

Phytother Res. 2001 Aug;15(5):449-51.

PMID:
11507743
19.

Overexpression of catalase in vascular smooth muscle cells prevents the formation of abdominal aortic aneurysms.

Parastatidis I, Weiss D, Joseph G, Taylor WR.

Arterioscler Thromb Vasc Biol. 2013 Oct;33(10):2389-96. doi: 10.1161/ATVBAHA.113.302175. Epub 2013 Aug 15.

20.

Suppression of experimental abdominal aortic aneurysms by systemic treatment with a hydroxamate-based matrix metalloproteinase inhibitor (RS 132908).

Moore G, Liao S, Curci JA, Starcher BC, Martin RL, Hendricks RT, Chen JJ, Thompson RW.

J Vasc Surg. 1999 Mar;29(3):522-32.

Supplemental Content

Support Center